Hjem › Akut lymfoblastisk leukemi › District of Columbia › Washington
Kliniske studier for Akut lymfoblastisk leukemi i Washington, DC
16 studier for Akut lymfoblastisk leukemi søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Rekrutterer
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi unna
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
RekruttererFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RekruttererFase 2
- Children's National Hospital, Washington D.C.
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Children's National Medical Center, Washington D.C.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
RekruttererFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7 mi unna
- Nih/Nhlbi, Bethesda · 7 mi unna
Massage Impact on Sleep in Pediatric Oncology
Rekrutterer
- Children's National Hospital, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Feasibility/Acceptability of Attentional-Control Training in Survivors
Rekrutterer
- Children's National Hospital, Washington D.C.
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
Rekrutterer
- Children's National Hospital, Washington D.C.
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 7 mi unna
Akut lymfoblastisk leukemi-studier i andre byer
- Houston, TX28 studier
- New York City, NY23 studier
- Seattle, WA21 studier
- Baldwin Park, CA21 studier
- Chicago, IL20 studier
- Atlanta, GA19 studier
- Memphis, TN16 studier
- Philadelphia, PA16 studier
- Boston, MA15 studier
- Los Angeles, CA14 studier
- Mountain View, CA13 studier
- Durham, NC13 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.